These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6287349)

  • 1. Opiate, enkephalin, and endorphin analgesia: relations to a single subpopulation of opiate receptors.
    Pasternak GW
    Neurology; 1981 Oct; 31(10):1311-5. PubMed ID: 6287349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irreversible opiate agonists and antagonists: the 14-hydroxydihydromorphinone azines.
    Hahn EF; Carroll-Buatti M; Pasternak GW
    J Neurosci; 1982 May; 2(5):572-6. PubMed ID: 6176696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opiate analgesia: evidence for mediation by a subpopulation of opiate receptors.
    Pasternak GW; Childers SR; Snyder SH
    Science; 1980 May; 208(4443):514-6. PubMed ID: 6245448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting opiate agonists and antagonists: 14-hydroxydihydromorphinone hydrazones.
    Pasternak GW; Hahn EF
    J Med Chem; 1980 Jun; 23(6):674-6. PubMed ID: 6156240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor binding and analgesic properties of oxymorphazone.
    Galetta S; Ling GS; Wolfin L; Pasternak GW
    Life Sci; 1982 Sep 20-27; 31(12-13):1389-92. PubMed ID: 6183551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naloxazone, a long-acting opiate antagonist: effects on analgesia in intact animals and on opiate receptor binding in vitro.
    Pasternak GW; Childers SR; Snyder SH
    J Pharmacol Exp Ther; 1980 Sep; 214(3):455-62. PubMed ID: 6105201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones.
    Hahn EF; Nishimura S; Goodman RR; Pasternak GW
    J Pharmacol Exp Ther; 1985 Dec; 235(3):839-45. PubMed ID: 2416909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxymorphone-naltrexonazine, a mixed opiate agonist-antagonist.
    Galetta S; Hahn EF; Nishimura S; Pasternak GW
    Life Sci; 1987 Aug; 41(6):783-7. PubMed ID: 2441221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxymorphazone: a long-acting opiate analgesic.
    Ling GS; Galetta S; Pasternak GW
    Cell Mol Neurobiol; 1984 Mar; 4(1):1-13. PubMed ID: 6204757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinal and supraspinal opioid analgesia in the mouse: the role of subpopulations of opioid binding sites.
    Ling GS; Pasternak GW
    Brain Res; 1983 Jul; 271(1):152-6. PubMed ID: 6309332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irreversible opiate agonists and antagonists. IV. Analgesic actions of 14-hydroxydihydromorphinone hydrazones.
    Williams CL; Bodnar RJ; Clark JE; Hahn EF; Burks TF; Pasternak GW
    J Pharmacol Exp Ther; 1988 Apr; 245(1):8-12. PubMed ID: 2452249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple mu opiate receptors.
    Pasternak GW; Wood PJ
    Life Sci; 1986 May; 38(21):1889-98. PubMed ID: 2872563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple opiate receptors: [3H]ethylketocyclazocine receptor binding and ketocyclazocine analgesia.
    Pasternak GW
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3691-4. PubMed ID: 6251477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Methylated naloxone, naltrexone, oxymorphone, and their 14-O-methyl ethers.
    Schmidhammer H; Leander JD; Mayer-Valkanover K; Nussbaumer C; Schmidt C; Schoepp DD; Schratz A; Walla-Kugler M
    Prog Clin Biol Res; 1990; 328():41-4. PubMed ID: 2154800
    [No Abstract]   [Full Text] [Related]  

  • 15. Classification of multiple morphine and enkephalin binding sites in the central nervous system.
    Wolozin BL; Pasternak GW
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6181-5. PubMed ID: 6273857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms.
    Ling GS; Spiegel K; Lockhart SH; Pasternak GW
    J Pharmacol Exp Ther; 1985 Jan; 232(1):149-55. PubMed ID: 2981312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 10-Ketonaltrexone and 10-ketooxymorphone.
    Archer S; Seyed-Mozaffari A; Ward S; Kosterlitz HW; Paterson SJ; McKnight AT; Corbett AD
    J Med Chem; 1985 Jul; 28(7):974-6. PubMed ID: 2409281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic supersensitivity and opioid receptor upregulation in the mouse.
    Yoburn BC; Nunes FA; Adler B; Pasternak GW; Inturrisi CE
    J Pharmacol Exp Ther; 1986 Oct; 239(1):132-5. PubMed ID: 3020228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological studies with an alkylating narcotic agonist, chloroxymorphamine, and antagonist, chlornaltrexamine.
    Caruso TP; Larson DL; Portoghese PS; Takemori AE
    J Pharmacol Exp Ther; 1980 Jun; 213(3):539-44. PubMed ID: 6162947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different receptors mediate morphine-induced prolactin and growth hormone release.
    Spiegel K; Kourides IA; Pasternak GW
    Life Sci; 1982 Nov 15-22; 31(20-21):2177-80. PubMed ID: 6298516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.